Medtronic Plc MDT
NYSE · Healthcare · Medical - Devices
$99.94
Close on Fri, 20 Nov 2026 · market value $128B
What the price is betting on
Below its recordAt $100, the price assumes revenue grows about 1.4% a year for five years, from $37.5B to about $40.1B by FY2031. That is less than what analysts expect for the next two years and less than the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 7.6% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than MDT? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$106
Base
$118
Bull
$132
Today $100
- Bear $106. Cash flow grows 2% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $118. Cash flow grows 4% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $132. Cash flow grows 6% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2027$37.9B$39B, on the path
- FY2028$38.5B$40.3B, on the path
- FY2029$39B$42.1B, on the path
- FY2030$39.5B$44.7B, on the path
- FY2031$40.1B$46B, on the path
Each year's revenue at 1.4% growth from $37.5B in the 12 months to July 2026.
At a glance
Healthcare · Medical - Devices · listed on NYSE
- Revenue, FY2026
- $36.4B
- Growth, 3 years a year
- 5.8%
- Cash margin
- 15%
- Net debt
- $18.7B
- Shares, 3-year change
- −4.7%
- Dividend yield
- 2.8%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.